Date: 2011-12-13
Type of information: Collaboration agreement
Compound: lead optimization services
Company: Prestwick Chemical (France) Pharma Plexus Holland (The Netherlands)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: The chemical services company for the life sciences industry, Prestwick Chemical, has formed a strategic alliance with Pharma Plexus Holland, a provider of pharmaceutical lead optimization and development services. The two companies will work together on a significant lead optimization project recently won from a major pharmaceutical company.
The new partnership means the two companies can offer enhanced professional multidisciplinary research services to life science companies worldwide. As well as lead optimization and library services, the two companies can now also provide large-scale synthesis services and expect to further integrate the drug discovery process.
Pharma Plexus Holland was recently founded by former scientists from Abbott Healthcare products in the Netherlands. Pharma Plexus Holland brings the highly reputed excellence of former Solvay Pharmaceuticals employees in pharmaceutical lead optimization to both big pharma and biotech partners.
The new project, details of which have not been disclosed, will involve scientists from Prestwick Chemical, Pharma Plexus Holland, and the customer working closely together to ensure the highest possible quality results.
Financial terms:
Latest news:
